Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1β in vitro

Clinical Oral Investigations

Volumn 16, Issue 1, 2012, Pages 275-283

  Nokhbehsaim, Marjan ^a   Deschner, Birgit ^a   Winter, Jochen ^a   Bourauel, Christoph ^a   Jäger, Andreas ^a   Jepsen, Søren ^a   Deschner, James ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Biomechanical loading; EMD; Inflammation; Periodontium; Wound healing

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; IL10 PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PTGS2 PROTEIN, HUMAN;

ARTICLE; BIOMECHANICS; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; MASTICATION; MECHANICAL STRESS; PERIODONTAL LIGAMENT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANTI-INFLAMMATORY AGENTS; BIOMECHANICS; BITE FORCE; CELLS, CULTURED; CYCLOOXYGENASE 2; DENTAL ENAMEL PROTEINS; DOWN-REGULATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; PERIODONTAL LIGAMENT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, MECHANICAL; TIME FACTORS;

EID: 84855927374     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-010-0505-8     Document Type: Article

References (44)

1. Graves DT, Cochran D (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74: 391-401.
2. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86: 306-319.
3. Noguchi K, Ishikawa I (2007) The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 43: 85-101.
4. Bartold PM, Cantley MD, Haynes DR (2010) Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 53: 55-69.
5. Deschner J, Arnold B, Kage A, Zimmermann B, Kanitz V, Bernimoulin JP (2000) Suppression of interleukin-10 release from human periodontal ligament cells by interleukin-1beta in vitro. Arch Oral Biol 45: 179-183.
6. Long P, Hu J, Piesco N, Buckley M, Agarwal S (2001) Low magnitude of tensile strain inhibits IL-1beta-dependent induction of pro-inflammatory cytokines and induces synthesis of IL-10 in human periodontal ligament cells in vitro. J Dent Res 80: 1416-1420.
7. Garrett S (1996) Periodontal regeneration around natural teeth. Ann Periodontol 1: 621-666.
8. Heitz-Mayfield L (2005) How effective is surgical therapy compared with nonsurgical debridement? Periodontology 2000 37: 72-87.
9. Bosshardt DD (2008) Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 35(8 Suppl): 87-105.
10. Cochran DL, King GN, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A (2003) The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Periodontol 74: 1043-1055.
11. Giannobile W, Somerman M (2003) Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 8: 193-204.
12. Jepsen S, Heinz B, Jepsen K, Arjomand M, Hoffmann T, Richter S, Reich E, Sculean A, Gonzales JR, Bödeker RH, Meyle J (2004) A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: study design and results for primary outcomes. J Periodontol 75: 1150-1160.
13. Venezia E, Goldstein M, Boyan B, Schwartz Z (2004) The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. Crit Rev Oral Biol Med 15: 382-402.
14. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV (2009) Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev (4): CD003875.
15. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Agren MS (2004) Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 12: 100-108.
16. Okuda K, Miyazaki A, Momose M, Murata M, Nomura T, Kubota T, Wolff LF, Yoshie H (2001) Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). J Periodontal Res 36: 309-316.
17. Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Brägger U, Lang NP, European Research Group on Periodontology (ERGOPERIO) (2004) Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 31: 1092-1098.
18. Wennström JL, Lindhe J (2002) Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 29: 9-14.
19. Aukhil I (2000) Biology of wound healing. Periodontol 2000 22: 44-50.
20. Häkkinen L, Uitto VJ, Larjava H (2000) Cell biology of gingival wound healing. Periodontol 2000 24: 127-152.
21. Parkar M, Tonetti M (2004) Gene expression profiles of periodontal ligament cells treated with enamel matrix proteins in vitro: analysis using cDNA arrays. J Periodontol 75: 1539-1546.
22. Myhre AE, Lyngstadaas SP, Dahle MK, Stuestøl JF, Foster SJ, Thiemermann C, Lilleaasen P, Wang JE, Aasen AO (2006) Anti-inflammatory properties of enamel matrix derivative in human blood. J Periodontal Res 41: 208-213.
23. Sato S, Kitagawa M, Sakamoto K, Iizuka S, Kudo Y, Ogawa I, Miyauchi M, Chu EY, Foster BL, Somerman MJ, Takata T (2008) Enamel matrix derivative exhibits anti-inflammatory properties in monocytes. J Periodontol 79: 535-540.
24. Hönig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F (1989) Increased interleukin-1 beta (IL-1 beta) concentration in gingival tissue from periodontitis patients. J Periodontal Res 24: 362-367.
25. Hou L, Liu C, Chang W (1994) Increased interleukin-1 beta levels in gingival crevicular fluid of Chinese periodontal patients. J Formos Med Assoc 93: 99-103.
26. Mathur A, Michalowicz B, Castillo M, Aeppli D (1996) Interleukin-1 alpha, interleukin-8 and interferon-alpha levels in gingival crevicular fluid. J Periodontal Res 31: 489-495.
27. Preiss D, Meyle J (1994) Interleukin-1 beta concentration of gingival crevicular fluid. J Periodontol 65: 423-428.
28. Deschner J, Rath-Deschner B, Reimann S, Bourauel C, Götz W, Jepsen S, Jäger A (2007) Regulatory effects of biophysical strain on rat TMJ discs. Ann Anat 189: 326-328.
29. Rath-Deschner B, Deschner J, Reimann S, Bourauel C, Jäger A, Götz W (2009) Regulatory effects of biomechanical strain on the IGF system in human periodontal cells. J Biomech 42: 2584-2589.
30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta C(T)) method. Methods 25: 402-408.
31. Harrel SK, Nunn ME, Hallmon WW (2006) Is there an association between occlusion and periodontal destruction?: yes-occlusal forces can contribute to periodontal destruction. JADA 137: 1380-1392.
32. Harrel SK, Nunn ME (2001) The effect of occlusal discrepancies on periodontitis. II. Relationship of occlusal treatment to the progression of periodontal disease. J Periodontol 72: 495-505.
33. Hoang AM, Oates TW, Cochran DL (2000) In vitro wound healing responses to enamel matrix derivative. J Periodontol 71: 1270-1277.
34. Rincon J, Haase H, Bartold P (2003) Effect of Emdogain on human periodontal fibroblasts in an in vitro wound-healing model. J Periodontal Res 38: 290-295.
35. Schwarz F, Rothamel D, Herten M, Sculean A, Scherbaum W, Becker J (2004) Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants. Clin Oral Investig 8: 165-171.
36. Takayama T, Suzuki N, Narukawa M, Tokunaga T, Otsuka K, Ito K (2005) Enamel matrix derivative stimulates core binding factor alpha1/Runt-related transcription factor-2 expression via activation of Smad1 in C2C12 cells. J Periodontol 76: 244-249.
37. Zeldich E, Koren R, Nemcovsky C, Weinreb M (2007) Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK. J Dent Res 86: 41-46.
38. Agarwal S, Long P, Seyedain A, Piesco N, Shree A, Gassner R (2003) A central role for the nuclear factor-kappaB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J 17: 899-901.
39. Johnson DL, Carnes D, Steffensen B, Cochran DL (2009) Cellular effects of enamel matrix derivative are associated with different molecular weight fractions following separation by size-exclusion chromatography. J Periodontol 80: 648-656.
40. Suzuki S, Nagano T, Yamakoshi Y, Gomi K, Arai T, Fukae M, Katagiri T, Oida S (2005) Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-{beta}. J Dent Res 84: 510-514.
41. Okubo K, Kobayashi M, Takiguchi T, Takada T, Ohazama A, Okamatsu Y, Hasegawa K (2003) Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 38: 1-9.
42. Hirano T (2010) Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc Jpn Acad B Phys Biol Sci 86: 717-730.
43. Blanchard F, Duplomb L, Baud'huin M, Brounais B (2009) The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev 20: 19-28.
44. Gaffen SL, Hajishengallis G (2008) A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.